• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性医院中因 COVID-19 而死亡的最年长老人的临终关怀:一项描述最后 24 小时内药物治疗的多中心研究。

Terminal care in oldest old dying from COVID-19 in the acute hospital : A multicenter study describing pharmacological treatment in the last 24 h.

机构信息

Department of Geriatrics, University Hospital Ghent, Ghent, Belgium.

出版信息

Z Gerontol Geriatr. 2022 Mar;55(2):129-134. doi: 10.1007/s00391-022-02036-4. Epub 2022 Mar 4.

DOI:10.1007/s00391-022-02036-4
PMID:35244764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8894836/
Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19) has a high mortality, especially in the oldest old. Dying from COVID-19 is often characterized by symptoms such as breathlessness and agitation but data concerning medical treatment in the dying phase are limited.

OBJECTIVE

This study describes the administration of oxygen, opioids and benzodiazepines in the last 24 h before death in patients 80 years or older dying from COVID-19 on acute hospital wards.

MATERIAL AND METHODS

In this multi-centric retrospective study, patients, 80 years and older, admitted to the acute hospital in March and April 2020 were recruited from 10 acute Belgian hospitals. They all were diagnosed with COVID-19 and died on non-ICU wards with COVID-19. Administration of oxygen, opioids and benzodiazepines in the last 24 h before death was registered.

RESULTS

Eighty-five percent of patients received oxygen, half of them even by means of a mask providing at least 10l oxygen per minute. The majority (84.3%) of patients were treated with opioids (morphine). Mean dosage of SC morphine equivalent was 31.3 mg/24 h (range 2-120 mg; SD 21.6 mg). More than half of patients (52.8%) received benzodiazepines, mostly midazolam. Mean dosage of midazolam was 20.4 mg/24 h (range 1-100 mg; SD 15.4 mg). Dosages of morphine and midazolam did not differ depending on frailty or comorbidities. Older COVID-19 patients dying with respiratory failure had higher midazolam dosage (p 0.002) but not morphine dosage (p 0.11).

CONCLUSION

A high proportion of patients 80 years and older and dying with COVID-19 in the hospital, were treated with oxygen, opioids and benzodiazepines in the last 24 h before death. With this descriptive study, we hope to contribute to the discussion and further research on the optimization of symptom control in an older population dying from/with COVID-19.

摘要

背景

2019 年冠状病毒病(COVID-19)死亡率较高,尤其是在最年长的人群中。死于 COVID-19 的人通常表现出呼吸困难和烦躁等症状,但有关临终阶段治疗的数据有限。

目的

本研究描述了在 2020 年 3 月至 4 月期间,10 家比利时急性医院的 80 岁及以上因 COVID-19 住院的患者在死亡前 24 小时内接受的氧气、阿片类药物和苯二氮䓬类药物的治疗情况。

材料和方法

在这项多中心回顾性研究中,招募了来自 10 家急性比利时医院的 80 岁及以上因 COVID-19 急性住院并在非 ICU 病房死亡的患者。他们均被诊断为 COVID-19,并且在 COVID-19 病房死亡。记录了在死亡前 24 小时内接受的氧气、阿片类药物和苯二氮䓬类药物的使用情况。

结果

85%的患者接受了氧气治疗,其中一半患者甚至通过提供至少 10L/分钟氧气的面罩进行氧疗。大多数(84.3%)患者接受了阿片类药物(吗啡)治疗。皮下注射吗啡等效剂量为 31.3mg/24h(范围 2-120mg;SD 21.6mg)。超过一半的患者(52.8%)接受了苯二氮䓬类药物治疗,主要是咪达唑仑。咪达唑仑的平均剂量为 20.4mg/24h(范围 1-100mg;SD 15.4mg)。吗啡和咪达唑仑的剂量与虚弱或合并症无关。因呼吸衰竭而死亡的老年 COVID-19 患者的咪达唑仑剂量较高(p0.002),但吗啡剂量无差异(p0.11)。

结论

在因 COVID-19 住院并死亡的 80 岁及以上患者中,很大一部分患者在死亡前 24 小时内接受了氧气、阿片类药物和苯二氮䓬类药物的治疗。通过这项描述性研究,我们希望为讨论和进一步研究优化因 COVID-19 死亡或伴有 COVID-19 的老年人群的症状控制做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d5/8894836/dc521e7d2275/391_2022_2036_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d5/8894836/b90ec64be7c1/391_2022_2036_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d5/8894836/10f899f9042c/391_2022_2036_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d5/8894836/dc521e7d2275/391_2022_2036_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d5/8894836/b90ec64be7c1/391_2022_2036_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d5/8894836/10f899f9042c/391_2022_2036_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d5/8894836/dc521e7d2275/391_2022_2036_Fig3_HTML.jpg

相似文献

1
Terminal care in oldest old dying from COVID-19 in the acute hospital : A multicenter study describing pharmacological treatment in the last 24 h.急性医院中因 COVID-19 而死亡的最年长老人的临终关怀:一项描述最后 24 小时内药物治疗的多中心研究。
Z Gerontol Geriatr. 2022 Mar;55(2):129-134. doi: 10.1007/s00391-022-02036-4. Epub 2022 Mar 4.
2
Pharmacological treatment in the dying geriatric patient: describing use and dosage of opioids in the acute geriatric wards and palliative care units of three hospitals.在临终老年患者中的药物治疗:描述三家医院的老年急性病房和姑息治疗病房中阿片类药物的使用和剂量。
Eur Geriatr Med. 2021 Jun;12(3):545-550. doi: 10.1007/s41999-021-00496-2. Epub 2021 Apr 20.
3
COVID-19 end-of-life care: symptoms and supportive therapy use in an Australian hospital.COVID-19 临终关怀:澳大利亚一家医院的症状和支持性治疗使用情况。
Intern Med J. 2021 Sep;51(9):1420-1425. doi: 10.1111/imj.15300.
4
End-of-life care in COVID-19: An audit of pharmacological management in hospital inpatients.COVID-19 患者的临终关怀:医院住院患者药物治疗管理的审计。
Palliat Med. 2020 Oct;34(9):1235-1240. doi: 10.1177/0269216320935361. Epub 2020 Jun 26.
5
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
6
An audit of end-of-life symptom control in patients with corona virus disease 2019 (COVID-19) dying in a hospital in the United Kingdom.对英国一家医院内死于 2019 冠状病毒病(COVID-19)的患者临终症状控制情况的审核。
Palliat Med. 2020 Oct;34(9):1249-1255. doi: 10.1177/0269216320947312. Epub 2020 Jul 31.
7
Death from COVID-19: management of breathlessness: a retrospective multicentre study.COVID-19 死亡:呼吸困难的管理:一项回顾性多中心研究。
BMJ Support Palliat Care. 2024 Jan 8;13(e3):e786-e789. doi: 10.1136/bmjspcare-2021-003150.
8
Palliative Care During COVID-19: Data and Visits From Loved Ones.新冠疫情期间的姑息治疗:数据与亲人探访
Am J Hosp Palliat Care. 2020 Nov;37(11):988-991. doi: 10.1177/1049909120943577. Epub 2020 Jul 24.
9
Palliative Sedation in COVID-19 End-of-Life Care. Retrospective Cohort Study.COVID-19 终末期患者的缓和性镇静。回顾性队列研究。
Medicina (Kaunas). 2021 Aug 26;57(9):873. doi: 10.3390/medicina57090873.
10
COVID-19: Symptoms in Dying Residents of Nursing Homes and in Those Admitted to Hospitals.COVID-19:疗养院临终居民和住院患者的症状。
J Palliat Med. 2021 Jul;24(7):1067-1071. doi: 10.1089/jpm.2020.0688. Epub 2021 Mar 5.

本文引用的文献

1
Early resuscitation orders in hospitalized oldest-old with COVID-19: A multicenter cohort study.COVID-19 住院超高龄患者的早期复苏医嘱:一项多中心队列研究。
Palliat Med. 2021 Jul;35(7):1288-1294. doi: 10.1177/02692163211018342. Epub 2021 May 24.
2
Pharmacological treatment in the dying geriatric patient: describing use and dosage of opioids in the acute geriatric wards and palliative care units of three hospitals.在临终老年患者中的药物治疗:描述三家医院的老年急性病房和姑息治疗病房中阿片类药物的使用和剂量。
Eur Geriatr Med. 2021 Jun;12(3):545-550. doi: 10.1007/s41999-021-00496-2. Epub 2021 Apr 20.
3
Letter to the Editor: Premorbid Frailty is a better Prognostic Indicator than Age in Oldest-Old Hospitalized with COVID-19.
致编辑的信:对于因 COVID-19 住院的高龄老人,病前虚弱是比年龄更好的预后指标。
J Am Med Dir Assoc. 2021 Mar;22(3):514-516. doi: 10.1016/j.jamda.2021.01.059. Epub 2021 Jan 18.
4
COVID-19 and Hospital Palliative Care - A service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist Hospital Palliative Care.COVID-19 和医院姑息治疗 - 一项服务评估,探讨了 186 名患者的症状和结果,以及大流行对专科医院姑息治疗的影响。
Palliat Med. 2020 Oct;34(9):1256-1262. doi: 10.1177/0269216320949786. Epub 2020 Aug 14.
5
Symptom Relief Is Possible in Elderly Dying COVID-19 Patients: A National Register Study.老年 COVID-19 临终患者的症状缓解成为可能:一项全国登记研究。
J Palliat Med. 2021 Apr;24(4):514-519. doi: 10.1089/jpm.2020.0249. Epub 2020 Jul 31.
6
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
7
End-of-life care in COVID-19: An audit of pharmacological management in hospital inpatients.COVID-19 患者的临终关怀:医院住院患者药物治疗管理的审计。
Palliat Med. 2020 Oct;34(9):1235-1240. doi: 10.1177/0269216320935361. Epub 2020 Jun 26.
8
Diabetes increases the mortality of patients with COVID-19: a meta-analysis.糖尿病使 COVID-19 患者的死亡率增加:一项荟萃分析。
Acta Diabetol. 2021 Feb;58(2):139-144. doi: 10.1007/s00592-020-01546-0. Epub 2020 Jun 24.
9
Characteristics, Symptom Management, and Outcomes of 101 Patients With COVID-19 Referred for Hospital Palliative Care.101 例因 COVID-19 转诊至医院姑息治疗的患者的特征、症状管理和结局。
J Pain Symptom Manage. 2020 Jul;60(1):e77-e81. doi: 10.1016/j.jpainsymman.2020.04.015. Epub 2020 Apr 20.
10
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.